Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using <sup>131</sup> I-LYM-1 Antibody - Concepedia

Concepedia

Publication | Closed Access

Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using <sup>131</sup> I-LYM-1 Antibody

95

Citations

26

References

1998

Year

Gerald L. DeNardo, Sally J. DeNardo, Kathleen R. Lamborn, D. Goldstein, Jerry P. Lewis, L.F. O'Grady, Antolin Raventos, Linda A. Kroger, Daniel J. Macey, John P. McGahan,

Cancer Biotherapy and Radiopharmaceuticals

Abstract

Although advanced disease often interrupted therapy prematurely, the results from 131I-Lym-1 therapy are clearly promising and warrant additional trials.

References

	Year	Citations

Page 1